Drugs Information: Pegademase
Basic Information
|
|
||
| ID | DDInter1402 | |
| Drug Type | biotech | |
| Molecular Formula | C1821H2834N484O552S14 | |
| Molecular Weight | - | |
| Description | Pegademase is a modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes. | |
| ATC Classification | L03AX04 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Pegademase
| Severity level | ID | Name | Mechanism | Detail |
|---|